Search for Clinical Trial Results

Hyperlipoproteinemia Type I - 48 Studies Found
Status | Study |
Terminated |
Study Name: Duration of Effect of Alipogene Tiparvovec Treatment, Which Was Administered in Other Studies Condition: Hyperlipoproteinemia Type I Date: 2011-09-28 |
Terminated |
Study Name: Extension to a Randomized, Double-blind, Placebo Controlled Study of LCQ908 in Subjects With Familial Chylomicronemia Syndrome. Condition: Familial Chylomicronemia Syndrome (FCS) (HLP Type I) Date: 2012-04-27 Interventions: Drug: LCQ908 |
Recruiting |
Study Name: Orlistat for the Treatment of Type I Hyperlipoproteinemia Condition:
Date: 2016-05-02 Interventions: Drug: Orlistat Orlistat is a gastric and pancreatic lipase inhibitor that is approved by the FDA for wei |
Completed |
Study Name: The APPROACH Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Patients With Familial Chylomicronemia Syndrome Condition: Familial Chylomicronemia Syndrome Date: 2014-08-05 Interventions:
|
Completed |
Study Name: A Randomized, Double-blind, Placebo Controlled Study to Assess Efficacy, Safety and Tolerability of LCQ908 in Subjects With Familial Chylomicronemia Syndrome Condition: Familial Chylomicronemia Syndrome (FCS) Date: 2011-12-21 Interventions:
|
Recruiting |
Study Name: The Approach Open Label Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Patients With Familial Chylomicronemia Syndrome Condition:
|
Recruiting |
Study Name: Alipogene Tiparvovec for the Treatment of LPLD Patients Condition: LPL Deficiency Date: 2016-05-10 Interventions:
|
Not yet recruiting |
Study Name: Lipoprotein Lipase Enzyme Activity Assay Validation and Clinical Assessment Condition: Lipoprotein Lipase Deficiency Date: 2016-01-12 Interventions: Drug: Heparin Participants will be given IV heparin in order to release lipoprotein lipase from capillar |
Not yet recruiting |
Study Name: Safety and Efficacy in LPL-Deficient Subjects of AMT-011, an Adeno-Associated Viral Vector Expressing Human Lipoprotein Lipase [S447X] Condition: Familial Lipoprotein Lipase Deficiency Date: 2010-04-22 Interventions:
|
Completed |
Study Name: Efficacy and Safety of Human Lipoprotein Lipase (LPL)[S447X] Expressed by an Adeno-Associated Viral Vector in LPL-deficient Subjects Condition: Familial Lipoprotein Lipase Deficiency Date: 2009-04-30 Interventions:
|